| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
11,911 |
9,961 |
$679K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,010 |
5,008 |
$528K |
| 99222 |
Initial hospital care, per day, moderate complexity |
3,979 |
3,514 |
$325K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
8,650 |
3,919 |
$312K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
3,704 |
3,298 |
$153K |
| 99223 |
Prolong inpt eval add15 m |
504 |
341 |
$56K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
399 |
280 |
$26K |
| 99233 |
Prolong inpt eval add15 m |
357 |
110 |
$17K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
2,135 |
1,640 |
$16K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
298 |
279 |
$14K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
562 |
440 |
$11K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
313 |
248 |
$5K |
| 99307 |
|
267 |
261 |
$3K |
| 99318 |
|
127 |
113 |
$3K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
215 |
162 |
$1K |
| 82947 |
|
537 |
407 |
$1K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
66 |
51 |
$1K |
| 90688 |
|
59 |
48 |
$869.42 |
| 99305 |
|
31 |
31 |
$869.30 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
14 |
14 |
$849.60 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
17 |
15 |
$395.55 |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
32 |
17 |
$324.47 |
| 81003 |
|
201 |
121 |
$283.60 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
13 |
12 |
$8.50 |
| 3078F |
|
3,370 |
2,631 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
1,280 |
1,180 |
$0.00 |
| 3077F |
|
1,811 |
1,464 |
$0.00 |
| G8753 |
Most recent systolic blood pressure >= 140 mmhg |
272 |
241 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
460 |
364 |
$0.00 |
| 3008F |
|
1,743 |
1,585 |
$0.00 |
| 3074F |
|
4,016 |
3,065 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
152 |
121 |
$0.00 |
| 3075F |
|
89 |
79 |
$0.00 |
| 3080F |
|
922 |
729 |
$0.00 |
| G8755 |
Most recent diastolic blood pressure >= 90 mmhg |
142 |
129 |
$0.00 |
| 1036F |
|
147 |
136 |
$0.00 |
| 3079F |
|
543 |
477 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
455 |
361 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
17 |
12 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
113 |
110 |
$0.00 |